Sanofi: global healthcare and pharmaceutical company

Disability Inclusion In Action

At Sanofi, we are committed to accessibility and disability inclusion through a holistic and best-in-class approach.

Digital at Sanofi

Digital is at the heart of our ambition to transform the practice of medicine. We take never-been-done before & make it reality. And we’re just getting started.

Fighting for Inclusion: "My disability won't stop me"

Athletes Ezra Frech, Nantenin Keita and Davide Morana don’t compete in the same category, but they all have something in common: they have overcome their disability and are now fulfilling their potential through their sporting careers.

Pleins feux sur nos partenaires: Kymera et Sanofi à la recherche de cibles en immunologie

La dégradation ciblée des protéines est une nouvelle approche thérapeutique qui pourrait avoir des implications majeures dans le domaine de l'immunologie et de l'inflammation.

Read the article

Sanofi Impulsions 2024

Discover Sanofi Impulsion 2024, a series of events that bridge science and sport to advance society.

Kids & Diabetes in Schools – Celebrating 10 Years of Impact

Since 2013, Sanofi has partnered with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes to deliver KiDS – Kids & Diabetes in Schools.

Sanofi Today

Read our latest articles

Dany Dann and Ezra Frech, World para athletics 2023

Paris 2024 Partnership

December 1, 2023

Fighting for Inclusion: "My disability won't stop me from achieving victory"

Read the article

Our latest news

December 7, 2023

Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology

Read the Press Release

December 1, 2023

Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to advance sustainability

Read the Press Release

November 27, 2023

Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease

Read the Press Release

November 9, 2023

Media Update: Sanofi completes closing for potential first-in-class vaccine against extraintestinal pathogenic E.coli (ExPEC)

Read the Press Release

See all press releases

Explore More

Diversity, Equity, and Inclusion Report

In the first full year of our new People and Culture strategy, Diversity, Equity, and Inclusion took center stage. This report celebrates the tangible progress we’ve made towards reflecting diversity in our leadership, unleashing the full potential of our people, and achieving impact in and beyond the workplace.

Read the document